promot
viral
replic
g
g
g
synchron
inhibit
viral
replic
indic
possibl
develop
cell
cyclemodifi
agent
especi
induc
g
g
g
arrest
novel
strategi
treat
hfmd
natur
product
play
pivot
role
drug
discoveri
develop
process
note
natur
product
embodi
privileg
structur
pure
synthet
chemic
librari
possess
characterist
therapeut
effect
chines
herb
natur
productbas
drug
discoveri
research
program
repres
import
avenu
drug
develop
includ
antivir
drug
exampl
emodin
activ
ingredi
sourc
herb
belong
genera
rheum
polygonum
rhamnu
senna
extract
herb
use
treatment
epidemicpron
diseas
emodin
shown
inhibit
replic
sever
acut
respiratori
syndrom
sar
viru
hepat
b
hbv
herp
simplex
virus
hsv
artemisinin
drug
obtain
plant
artemisia
annua
recommend
treatment
infect
drugresist
plasmodium
falciparum
strain
cerebr
malaria
malaria
children
major
saponin
herb
astragalosid
shown
possess
anticanc
antifatigu
anticoxsacki
b
viru
antiinflammatori
effect
howev
date
activ
well
investig
present
studi
aim
elucid
activ
natur
activ
compon
rheum
emodin
astragalosid
artemisinin
observ
rheum
emodin
protect
host
cell
infect
decreas
viral
genom
level
viral
protein
express
decreas
virul
interven
cell
cycl
environ
favor
viral
replic
howev
astragalosid
artemisinin
show
similar
abil
result
reinforc
model
viral
pathogen
mechan
requir
regul
cell
cycl
environ
suggest
rheum
emodin
potenti
candid
treatment
prevent
hmdf
diseas
strain
report
previous
viru
strain
propag
african
green
monkey
kidney
cell
vero
vero
purchas
atcc
manassa
va
usa
maintain
dulbecco
modifi
eagl
medium
dmem
hyclon
logan
ut
usa
supplement
fetal
bovin
serum
fb
gibco
brl
grand
island
ny
usa
viral
titer
determin
measur
microtitr
assay
use
vero
cell
describ
previous
briefli
vero
cell
seed
onto
plate
incub
h
viruscontain
supernat
serial
dilut
ad
per
well
octupl
cytopath
effect
observ
per
day
experiment
endpoint
reach
determin
reedmuench
method
base
assumpt
produc
plaqu
form
unitsml
wwwprotocolonlineorg
cell
mockinfect
infect
moi
h
aafter
h
viru
adsorpt
cell
wash
pb
fresh
cultur
medium
ad
cell
growth
inhibit
test
inhibit
cell
growth
determin
mtt
sigma
st
loui
mo
usa
assay
cell
cellswel
seed
onto
cultur
plate
nunc
roskild
denmark
h
incub
differ
concentr
rheum
emodin
rheu
artemisinin
art
astragalosid
astra
purchas
nation
institut
control
pharmaceut
biolog
product
beij
china
ad
individu
plate
follow
incub
cell
growth
measur
h
addit
bromid
mtt
mgml
h
dmso
ad
dissolv
formazan
crystal
absorb
measur
nm
enzymelink
immunosorb
assay
plate
elisa
reader
biorad
hercul
ca
usa
percentag
inhibit
calcul
follow
inhibitori
ratio
control
sampl
control
blank
observ
cytopath
effect
cell
grown
cultur
dish
infect
h
morpholog
chang
observ
microscop
photograph
taken
olympu
tokyo
japan
nuclear
stain
hoechst
sigma
st
loui
mo
usa
use
visual
nuclear
chang
fluoresc
microscopi
briefli
cell
plate
onto
plastic
cultur
dish
cellswel
infect
h
treat
drug
h
wash
pb
fix
formaldehyd
h
wash
pb
stain
mgl
hoechst
min
nuclear
chang
observ
fluoresc
microscop
excit
wavelength
nm
emiss
filter
nm
leica
nussloch
germani
cell
cycl
analysi
flow
cytometri
nuclear
dna
content
measur
use
propidium
iodid
pi
stain
fluorescenceactiv
cell
sort
fac
adher
cell
collect
treatment
trypsin
wash
phosphatebuff
salin
pb
cell
analyz
viru
present
supernat
intracellular
viru
total
viru
made
ml
dmem
medium
subject
repeat
freez
thaw
three
cycl
subsequ
sampl
centrifug
round
per
minut
min
supernat
contain
viru
collect
intracellular
viru
total
viru
obtain
centrifug
round
per
minut
three
hour
sucros
use
type
ti
rotor
beckman
ultracentrifug
optim
ultracentrifug
beckman
coulter
sampl
collect
western
blot
analysi
determin
cyclin
cdk
express
cell
collect
h
infect
lyse
directli
sodium
dodecyl
sulfat
sd
sampl
buffer
mmoll
trishcl
ph
sd
glycerol
bromophenol
blue
follow
boil
min
wholecel
lysat
subject
sdspage
protein
transfer
nitrocellulos
membran
biorad
detect
correspond
primari
alkalin
phosphataseconjug
secondari
antibodi
membran
react
bcip
nitroblu
tetrazolium
nbt
substrat
sigma
anticdk
boster
anticyclin
proteintech
mous
rabbit
antibodi
use
western
blot
analys
polyclon
antibodi
rabbit
prepar
laboratori
rabbit
mous
secondari
antibodi
obtain
proteintech
intens
band
calcul
imagej
nih
imagej
valu
condrug
refer
intens
protein
band
control
groupth
intens
protein
band
drug
treatment
group
supernat
intracellular
total
viru
quantit
realtim
pcr
rna
extract
infect
cell
treat
control
medium
drug
use
trizol
reagent
gibcobrl
rockvil
md
usa
isol
specifi
manufactur
rna
treat
dnase
dnase
irnasefre
ambion
remov
contamin
dna
ng
total
rna
reversetranscrib
oligo
dt
primer
use
high
capac
cdna
rt
kit
appli
biosystem
cdna
reaction
specifi
manufactur
quantit
pcr
templat
cdna
ad
reaction
sybr
green
pcr
master
mix
appli
biosystem
primer
gapdh
forward
revers
primer
sequenc
gapdh
cttga
amplif
carri
use
abi
prism
cycl
follow
condit
initi
denatur
min
cycl
min
cycl
min
fold
chang
calcul
rel
gapdh
use
method
sequenc
analysi
data
present
deviat
sd
betweengroup
differ
assess
use
student
ttest
p
valu
consid
statist
signific
prove
antiviru
effect
rheum
emodin
artemisinin
astragalosid
cell
due
cytotox
cell
treat
rheum
emodin
artemisinin
astragalosid
variou
dose
confirm
abil
inhibit
cell
growth
human
lung
fibroblast
cell
although
infect
mainli
lead
central
nervou
system
symptom
lung
also
infect
viru
vivo
mean
cell
use
cell
model
cell
inhibitori
ratio
detect
via
mtt
analysi
h
posttreat
h
treatment
rheum
emodin
concentr
inhibitori
ratio
rang
figur
artemisinin
astragalosid
treatment
h
concentr
artemisinin
inhibitori
ratio
rang
figur
concentr
astragalosid
inhibitori
ratio
rang
figur
therefor
rang
concentr
rheum
emodin
artemisinin
astragalosid
affect
cell
surviv
base
result
publish
studi
mtt
assay
chose
follow
concentr
studi
rheum
emodin
artemisinin
astragalosid
activ
figur
illustr
flow
diagram
treat
cell
design
experi
exclud
possibl
antivir
effect
rheum
emodin
artemisinin
astragalosid
due
cytotox
effect
well
confirm
protect
effect
host
cell
rheum
emodin
artemisinin
astragalosid
chosen
base
previou
result
treat
mockinfect
infect
cell
h
effect
observ
either
cell
viabil
morpholog
infect
cell
figur
compar
mockinfect
cell
figur
meanwhil
observ
numer
cell
round
detach
bottom
dish
cell
morpholog
analysi
figur
compar
mockinfect
cell
h
postinfect
infect
moi
figur
rheum
emodin
treatment
figur
inhibit
cell
morpholog
chang
includ
round
detach
bottom
dish
due
infect
artemisinin
figur
astragalosid
figur
nuclear
stain
test
also
complet
confirm
effect
rheum
emodin
artemisinin
astragalosid
cell
death
cell
nuclei
becam
condens
bright
figur
indic
cell
death
rheum
emodin
treatment
inhibit
appear
condens
bright
nuclei
induc
infect
figur
neither
artemisinin
figur
astragalosid
inhibit
cell
death
induc
infect
figur
therefor
rheum
emodin
possess
abil
protect
host
cell
viral
damag
artemisinin
astragalosid
unabl
achiev
result
effect
rheum
emodin
artemisinin
astragalosid
viral
genom
rna
replic
examin
whether
viral
rna
replic
andor
transcript
influenc
treatment
drug
assess
sequenc
level
qrt
pcr
h
postinfect
singlestrand
positivesens
rna
genom
detect
sequenc
level
equival
detect
level
genom
rna
level
rheum
emodintr
cell
significantli
lower
control
cell
control
cell
figur
figur
thu
rheum
emodin
persist
inhibit
express
viral
protein
artemisinin
astragalosid
show
sustain
inhibitori
effect
viral
protein
express
extend
period
time
understand
inhibitori
effect
drug
product
viral
examin
h
postinfect
evalu
viral
virul
found
mocktreat
cell
rheum
emodintr
cell
remain
artemisininand
astragalosidetr
cell
tabl
furthermor
also
observ
fold
increas
mocktreat
cell
rheum
emodintr
cell
tabl
thu
artemisinin
astragalosid
inhibit
viral
product
rheum
emodin
exhibit
signific
inhibitori
effect
viral
reproduct
previou
studi
found
viru
induc
cell
cycl
arrest
phase
promot
viral
replic
g
g
g
synchron
inhibit
viral
replic
therefor
examin
whether
effect
emodin
figur
artemisinin
treatment
decreas
phase
p
infect
figur
astragalosid
treatment
also
induc
decreas
p
infect
figur
emphas
effect
rheum
emodin
artemisinin
astragalosid
treatment
phase
cell
analyz
percentag
phase
cell
infect
percentag
phase
cell
rheum
emodin
treatment
observ
mocktreat
cell
figur
correspond
phase
percentag
astragalosideand
artemisinintr
cell
figur
mocktreat
cell
figur
respect
thu
find
suggest
rheum
emodin
inhibit
sphase
accumul
induc
infect
western
blot
perform
observ
express
cdk
cyclin
h
postinfect
time
point
chosen
accord
previou
studi
signific
decreas
cdk
cyclin
observ
viralinfect
cell
compar
mockinfect
cell
rheum
emodin
decreas
express
cdk
increas
express
cyclin
cell
figur
effect
observ
either
artemisinin
figur
astragalosid
treatment
figur
therefor
rheum
emodin
appear
inhibit
manipul
host
cell
cycl
viru
regul
cdk
cyclin
express
human
enteroviru
primari
caus
agent
infect
infect
con
control
rheu
rheum
emodin
art
artemisinin
astra
astragalosid
tabl
fold
infect
infect
con
control
rheu
rheum
emodin
art
artemisinin
astra
astragalosid
hfmd
outbreak
asian
countri
develop
viral
vaccin
inhibitor
target
variou
phase
lifecycl
current
preclin
stage
current
avail
antivir
drug
limit
efficaci
infect
chines
herb
use
prevent
treatment
epidem
diseas
sinc
ancient
time
studi
investig
effect
three
natur
ingredi
rheum
emodin
astragalosid
artemisinin
extract
chines
herb
viral
replic
cell
death
led
loss
function
damag
cell
exampl
neural
cell
death
lead
amnesia
mental
disord
condit
muscl
cell
death
lead
outcom
paralysi
myasthenia
cell
death
also
lead
releas
cellular
content
eventu
inflamm
mani
studi
complet
vivo
vitro
identifi
inflammatori
factor
releas
cell
death
studi
found
rheum
emodin
abil
protect
host
cell
damag
associ
viral
infect
therefor
rheum
emodin
inhibit
cell
death
caus
viru
infect
ultim
inhibit
loss
host
function
inflammatori
occurr
cell
death
viral
infect
usual
due
viral
replic
henc
investig
whether
rheum
emodin
inhibit
viral
replic
result
clearli
indic
rheum
emodin
decreas
level
viral
genom
level
viral
protein
express
virul
compar
controltr
group
therefor
rheum
emodin
inhibit
cell
death
inhibit
viral
product
fold
differ
mrna
level
protein
express
controltr
rheum
emodintr
cell
artemisia
carvifolia
astragalu
previou
studi
show
induc
cell
cycl
arrest
phase
facilit
viral
product
howev
rheum
emodin
decreas
amount
phase
favor
increas
ratio
g
g
phase
compar
control
medium
con
astragalosid
astra
treatment
h
f
phase
percentag
compar
control
medium
con
drug
treatment
group
infect
cell
c
e
g
control
medium
con
rheum
emodin
treatment
rheu
h
c
control
medium
con
artemisinin
art
treatment
h
e
control
medium
con
astragalosid
astra
treatment
h
g
result
indic
one
experi
repres
three
independ
experi
p
control
treatment
studi
addit
express
cdk
cyclin
demonstr
role
rheum
emodin
cell
cycl
regul
therefor
conclud
rheum
emodin
inhibit
viral
replic
interven
cell
cycl
environ
favor
viru
although
artemisinin
astragalosid
also
display
abil
decreas
amount
phase
favor
viru
effect
potent
rheum
emodin
inde
appear
overcom
inhibitori
effect
artemisinin
astragalosid
h
previou
studi
exogen
express
rnadepend
rna
polymeras
shown
mediat
cell
cycl
arrest
therefor
specul
rheum
emodin
might
affect
function
viral
replic
knowledg
member
flavivirida
famili
includ
hepat
c
hcv
dengu
viru
classic
swine
fever
also
induc
sphase
arrest
notabl
picornavirida
flavivirida
share
common
characterist
singlestrand
positivesens
rna
virus
therefor
rheum
emodin
may
effect
singlestrand
positivesens
rna
virus
favor
phase
result
prove
understand
viral
pathogen
mechan
indic
rheum
emodin
potenti
candid
treatment
prevent
hmdf
diseas
figur
western
blot
show
effect
rheum
emodin
artemisinin
astragalosid
express
host
cell
cycl
regulatori
protein
infect
cell
mockinfect
infect
moi
h
two
hour
later
cell
treat
drug
last
h
cell
collect
lysi
cyclin
express
detect
western
blot
analysi
control
medium
rheum
emodin
rheu
treatment
h
control
medium
artemisinin
art
treatment
h
b
control
medium
astragalosid
astra
treatment
h
c
histon
tubulin
shown
load
control
result
repres
three
independ
experi
